Kerri Fitzgerald

DocwireNews

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, the U.S. Food and Drug Administration (FDA) approved two new drugs, new studies assessed triplet therapies for various cancers, and more.The addition of <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/study-identifies-triplet-combination-for-heavily-pretreated-her2-breast-cancer/">tucatinib to trastuzumab and capecitabine</a> better improved overall survival and progression-free survival (primary endpoint) compared with the addition of placebo in women with human epidermal growth factor receptor 2-positive metastatic&nbsp;breast cancer, according to a study published in&nbsp;The New England Journal of Medicine.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/fda-approves-novel-bladder-cancer-treatment/">The FDA granted accelerated approval to Padcev&trade;</a> (enfortumab vedotin-ejfv) for adults with previously treated locally advanced or metastatic&nbsp;urothelial cancers.The outcomes of a randomized, phase III trial showed that adding <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/tecentriq-cotellic-and-zelboraf-triple-threat-trumps-melanoma/">Tecentriq&nbsp;(atezolizumab) to Cotellic&nbsp;(cobimetinib) and Zelboraf&nbsp;(vemurafenib)</a> successfully reduced the risk of disease progression or death in patients with previously untreated BRAF V600 mutation-positive&nbsp;advanced&nbsp;melanoma.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/fda-approves-xtandi-for-metastatic-castration-sensitive-prostate-cancer/">The FDA approved a supplemental new drug application for Xtandi&reg;</a> (enzalutamide) for the treatment of metastatic castration-sensitive&nbsp;prostate cancer.In case you missed it, more hem/onc headlines are featured below:<ul>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/oral-formulation-of-paclitaxel-improves-response-compared-with-iv/">Oral Formulation of Paclitaxel Improves Breast Cancer Response Compared With IV</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/potential-blood-cancer-vaccine-formula/">A Potential Blood Cancer Vaccine Formula</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/pancreatic-cancer-treatment-and-tumor-biology-differences-by-race/">Pancreatic Cancer Treatment and Tumor Biology Differences by Race</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/africanamericans-with-cancer-at-risk-for-bloodclots/">African Americans with Cancer at Higher Risk for Blood Clots</a></li>
</ul>

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Latest News

Hem/Onc Roundup: New Triplet Combos for Breast Cancer and Melanoma, FDA Approvals, and more

Oncology

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, the U.S. Food and Drug Administration (FDA) approved two new ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe